Sofia Heigis, CEO, and David Augustsson, Head of IR, discusses the recent announcement of net sales for the first quarter and collaboration with Vector Pharma to commercialize Oncopeptides’ flagship drug Pepaxti in the Middle East and North Africa (MENA) region.
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
